FDP
INDV icon

Financiere des Professionnels’s Indivior Pharmaceuticals INDV Stock Holding History

Financiere des Professionnels’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,917
Closed -$363K – 383
2026
Q1 		$363K Hold
11,917
– – 0.02% 259
2025
Q4 		$428K Buy
11,917
+2,502
+27% +$76.4K 0.02% 232
2025
Q3 		$227K Buy
+9,415
New +$197K 0.01% 313

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financiere des Professionnels's INDV Position: Q2 2026 in Review

Financiere des Professionnels sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 11,917 shares — an estimated $363K sold.

Financiere des Professionnels first reported a position in INDV in Q3 2025 and held it in 3 quarters. The position peaked at $428K in Q4 2025. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Financiere des Professionnels reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Financiere des Professionnels sold 11,917 Indivior Pharmaceuticals shares in Q2 2026, an estimated $363K.
  • Financiere des Professionnels first reported a position in Indivior Pharmaceuticals in Q3 2025 and held it in 3 quarters.
  • Financiere des Professionnels's Indivior Pharmaceuticals position peaked at $428K in Q4 2025.
  • 339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.